121 related articles for article (PubMed ID: 1686349)
1. 2-Chlorodeoxyadenosine chemotherapy triggers programmed cell death in normal and malignant lymphocytes.
Carrera CJ; Piro LD; Saven A; Beutler E; Terai C; Carson DA
Adv Exp Med Biol; 1991; 309A():15-8. PubMed ID: 1686349
[No Abstract] [Full Text] [Related]
2. Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine.
Carson DA; Wasson DB; Esparza LM; Carrera CJ; Kipps TJ; Cottam HB
Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2970-4. PubMed ID: 1348362
[TBL] [Abstract][Full Text] [Related]
3. Pentostatin and 2-chlorodeoxyadenosine for hairy-cell leukemia.
Med Lett Drugs Ther; 1992 Sep; 34(879):89-90. PubMed ID: 1355592
[No Abstract] [Full Text] [Related]
4. Activity of 2-chloro-2'-deoxyadenosine in chronic lymphocytic leukemia, hairy cell leukemia, and autoimmune hemolytic anemia.
Carson DA; Piro LD; Wasson DB; Carrera CJ; Beutler E
Adv Exp Med Biol; 1989; 253A():427-31. PubMed ID: 2576181
[No Abstract] [Full Text] [Related]
5. A dual anti-tumor effect of a combination of interferon-alpha and 5-flurouracil or 2-chlorodeoxyadenosine on natural killer (NK) cell mediated cytotoxicity.
Reiter Z; Ozes ON; Tomson S; Blatt LM; Taylor MW
Adv Exp Med Biol; 1991; 309A():69-73. PubMed ID: 1686352
[No Abstract] [Full Text] [Related]
6. Induction of DNA double-strand breaks in Chinese hamster V79 cells by 2-chlorodeoxyadenosine.
Tanabe K; Hiraoka W; Kuwabara M; Sato F; Matsuda A; Ueda T
Chem Biol Interact; 1989; 71(2-3):167-75. PubMed ID: 2574637
[TBL] [Abstract][Full Text] [Related]
7. 2-chlorodeoxyadenosine (2-CdA) does not change the expression of Fas antigen on chronic lymphocytic leukaemia cells.
Gora-Tybor J; Lech-Miranda E; Blonski JZ; Robak T
Adv Exp Med Biol; 2000; 486():307-10. PubMed ID: 11783506
[No Abstract] [Full Text] [Related]
8. New purine analogues for the treatment of chronic B-cell malignancies.
Gribbin TE
Henry Ford Hosp Med J; 1991; 39(2):98-102. PubMed ID: 1679757
[TBL] [Abstract][Full Text] [Related]
9. The mechanism of 2-chlorodeoxyadenosine-induced cell death.
Wataya Y; Hirota Y; Hiramoto-Yoshioka A; Tanaka S; Otani T; Minowada J; Matsuda A; Ueda T
Adv Exp Med Biol; 1989; 253B():227-34. PubMed ID: 2575349
[No Abstract] [Full Text] [Related]
10. Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine.
Piro LD; Carrera CJ; Carson DA; Beutler E
N Engl J Med; 1990 Apr; 322(16):1117-21. PubMed ID: 1969613
[TBL] [Abstract][Full Text] [Related]
11. Clinical trials referral resource. Clinical trials with 2-chlorodeoxyadenosine.
Cheson BD
Oncology (Williston Park); 1992 May; 6(5):95-8. PubMed ID: 1350917
[No Abstract] [Full Text] [Related]
12. Response to 2-chlorodeoxyadenosine in patients with B-cell chronic lymphocytic leukemia resistant to fludarabine.
Juliusson G; Elmhorn-Rosenborg A; Liliemark J
N Engl J Med; 1992 Oct; 327(15):1056-61. PubMed ID: 1355853
[TBL] [Abstract][Full Text] [Related]
13. Profound toxicity of deoxyadenosine and 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo.
Carrera CJ; Yamanaka H; Piro LD; Lotz M; Carson DA
Adv Exp Med Biol; 1989; 253B():219-25. PubMed ID: 2575348
[TBL] [Abstract][Full Text] [Related]
14. [A new effective therapy of hairy cell leukemia and other lymphoproliferative diseases].
Juliusson G; Liliemark J
Lakartidningen; 1991 Aug; 88(35):2746-9. PubMed ID: 1680209
[No Abstract] [Full Text] [Related]
15. dNTP imbalance and DNA double strand breaks in mouse FM3A cells and the mechanism of cell death.
Wataya Y; Watanabe K; Yoshida S; Hiramoto-Yoshioka A
Nucleic Acids Symp Ser; 1989; (21):11-2. PubMed ID: 2575244
[TBL] [Abstract][Full Text] [Related]
16. 2-Chlorodeoxyadenosine: hairy cell leukemia takes a surprising turn.
Beutler E; Carson DA
Blood Cells; 1993; 19(3):559-68; discussion 569-72. PubMed ID: 8018939
[TBL] [Abstract][Full Text] [Related]
17. Tumor lysis syndrome after treatment of chronic lymphocytic leukemia with cladribine.
Trendle MC; Tefferi A
N Engl J Med; 1994 Apr; 330(15):1090. PubMed ID: 8127350
[No Abstract] [Full Text] [Related]
18. Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro.
Ganeshaguru K; Wickremasinghe RG; Jones DT; Gordon M; Hart SM; Virchis AE; Prentice HG; Hoffbrand AV; Man A; Champain K; Csermak K; Mehta AB
Haematologica; 2002 Feb; 87(2):167-76. PubMed ID: 11836167
[TBL] [Abstract][Full Text] [Related]
19. 2-Chlorodeoxyadenosine treatment of lymphoid malignancies.
Piro LD
Blood; 1992 Feb; 79(4):843-5. PubMed ID: 1346575
[No Abstract] [Full Text] [Related]
20. Programmed cell death and adenine deoxynucleotide metabolism in human lymphocytes.
Carson DA; Carrera CJ; Wasson DB; Yamanaka H
Adv Enzyme Regul; 1988; 27():395-404. PubMed ID: 2907967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
